PDP1 and pre-descemet corneal dystrophy: Inhibitors of PDH, which is the gatekeeper between glycolysis and the TCA cycle, are good candidates in this regard, and use of pyruvate dehydrogenase complex deficiency (PDCD) cells would be a useful way to assess the reliability of this approach69.